Related Experiment Video
Updated: May 5, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
Evolution of pneumococcal serotype 19A in children in Bangladesh: insights from genomic analysis
Arif Mohammad Tanmoy1, Esha Kazi1, Naito Kanon1
1Child Health Research Foundation, Dhaka, Bangladesh.
Insights
Invasive pneumococcal disease (IPD) caused by Streptococcus pneumoniae serotype 19A did not increase in Bangladeshi children after PCV10 vaccine introduction. Continuous genomic surveillance is crucial due to evolving local 19A strains and increasing macrolide resistance.
Area of Science:
- Microbiology
- Genomics
- Epidemiology
Background:
- Invasive pneumococcal disease (IPD) caused by Streptococcus pneumoniae is a significant global health threat, especially for children.
- Serotype 19A is noted for multidrug resistance (MDR) and increased incidence post-vaccine introduction in many regions.
- Bangladesh introduced the 10-valent pneumococcal conjugate vaccine (PCV10) in 2015, anticipating a low burden of serotype 19A.
Purpose of the Study:
- To investigate the hospital incidence of serotype 19A in children under five years old in Bangladesh before and after PCV10 introduction.
- To conduct a comprehensive genomic analysis of serotype 19A isolates to understand population structure, antimicrobial resistance, and evolutionary dynamics.
- To assess the impact of PCV10 introduction on the prevalence of specific 19A lineages and their resistance patterns.
Main Methods:
- Longitudinal IPD surveillance data from 2004 to 2023 were analyzed for hospital incidence trends of serotype 19A.
- Whole-genome sequencing was performed on 153 serotype 19A isolates from various sample types (IPD, otitis media, carriage, urine).
- Phylogenetic and Bayesian Evolutionary Analysis Sampling Trees (BEAST) analyses were employed to determine population structure, global pneumococcal sequence clusters (GPSCs), sequence types (STs), and antimicrobial resistance genes, comparing them with global 19A genomes.
Main Results:
- No increase in hospital IPD incidence due to serotype 19A was observed post-PCV10 introduction.
- The multidrug-resistant 19A-ST320 lineage (GPSC1) was notably absent in Bangladesh.
- A new dominant lineage, ST12888 (GPSC84) carrying the 19A subtype-I (19A-I) capsular locus, emerged and increased from 15% to 70% post-PCV10 introduction.
- Increasing macrolide resistance was detected within the 19A-I/GPSC84 lineage, with estimated origins between 2007 and 2011.
Conclusions:
- The study supports Bangladesh's decision to implement PCV10 based on pre-vaccination serotype burden data.
- The emergence and rapid spread of the 19A-I/GPSC84 lineage highlight the dynamic nature of pneumococcal populations.
- Continuous epidemiological and genomic surveillance is essential for monitoring vaccine effectiveness and adapting public health strategies against evolving Streptococcus pneumoniae strains.
Background:
Invasive pneumococcal disease (IPD), caused by Streptococcus pneumoniae, remains a major global health concern, particularly for children. Among more than 100 pneumococcal serotypes, 19A is known for its multidrug resistance (MDR) and increased incidence following PCV7/PCV10 introduction in many countries. Bangladesh introduced PCV10 in 2015 considering the low burden of 19A in the country.
Methods:
Utilizing our IPD surveillance from 2004 to 2023, we investigated the hospital incidence of serotype 19A before and after PCV10 introduction among < 5 years old children in Bangladesh. Whole-genome sequencing was done for 153 serotype 19A isolates from IPD, otitis media, carriage, and urine samples. We used phylogenetic and BEAST analyses to investigate population structure, circulating subtypes, global pneumococcal sequence clusters (GPSCs), sequence types (STs), and antimicrobial resistance genes, and compared them with global 19A genomes.
Results:
Our findings indicate no increase in hospital IPD incidence due to serotype 19A following PCV10 introduction. The MDR 19A-ST320 lineage (GPSC1) remains absent in Bangladesh. ST12888 (GPSC84) became dominant in the post-PCV10 introduction (from 15% to 70%). GPSC84 carries the capsular locus of 19A subtype-I (19A-I), which emerged independently from the standard 19A locus. Macrolide resistance is increasing within the 19A-I/GPSC84 lineage and is estimated to have originated between 2007 and 2011.
Conclusions:
This study presents the first comprehensive genomic analysis of the serotype 19A population in Bangladesh, supporting the decision to introduce PCV10 in Bangladesh based on local pneumococcal serotype burden data. However, the rapid evolution within the local 19A population highlights the need for continuous epidemiological and genomic surveillance to support effective vaccination programs.
Related Concept Videos
Evolution of Microbial Genome
Atypical Pneumonia
Mechanism of Antibiotic Resistance in MRSA

